Wilson HD. How Boehringer Ingelheim Incorporates Patient Feedback into Trial Design. 2021. Patient.

Wilson HD, Anatchkova M, Gelhorn H. A Perspective on the 21st Century Cures Act: Patient Focused Drug Development. 2017. The Evidence Forum.

Wilson HD, Bull J, Campbell M, Gordon L. Are Patients at the Center of Your Trials? Using Patient Engagement and Insights to Improve Clinical Research. 2018. The Evidence Forum.

Wilson HD. From research through commercialization: Operationalizing the integration of patient insights. Patients as Partners USA, 2022, Philadelphia, PN.

Wilson HD, Cleonette CD, Horonjeff J. Practice Follows Principles: Creating More Inclusive Patient-Centered Development & Commercialization. DIA Global, Apr 2021.

Wilson HD. How to Build a Patient-Reported Outcome Measure. (November 2015). Presented at: The Pulmonary Fibrosis Foundation Annual Meeting, Washington DC, United States.

Wilson HD, Yale K. A systematic approach to patient-focused drug development. National Health Council Science of Patient Engagement Annual Meeting. 30 September 2020, virtual.

Wilson HD, Horonjeff J. Addressing diversity & inclusion across the continuum of drug development. Patients as Partners USA. 16-18 March 2021. Virtual

Wilson HD. Reuters Event Pharma USA. Enabling faster, more representative patient engagement. June 2021. Virtual.

Wilson H, Dashiell-Aje E, Anatchkova M, Coyne K, Hareendran A, Leidy NK, McHorney C, Wyrwich K. Beyond study participants: A framework for engaging patients in the selection or development of clinical outcomes assessments for evaluating the benefits of treatment in medical product development. Quality of Life Research, 2018; 27 (1): 5-16.

Ong SH, Kawata AK, Kulich K, Wilson H, Coyne KS, Evripidou P, Koutsides P, Kyriakidou-Himonas M, Loizou T, Olympios G, Pastellas C, Picolos M, Stylianou A, Toufexis C, Therapontos C. (November 2014). Psychometric evaluation of the Hypoglycemia Perspectives Questionnaire in patients with Type 2 Diabetes Mellitus. Poster presented at the 17th ISPOR Annual European Congress, Amsterdam, Netherlands.

Wilson H, Jordan R, Spana C, Revicki D. (October 2015). Measurement Properties of the Female Sexual Function Index Desire Domain in Women with Female Sexual Arousal Disorder. Oral Presentation at International Society for Quality of Life (ISOQOL) 22nd Annual Conference, Vancouver BC, Canada.

Kawata AK, Wilson H, Ong SH, Kulich K, Coyne K. Development and Psychometric Evaluation of the Hypoglycemia Perspectives Questionnaire in Patients with Type 2 Diabetes Mellitus. Patient. 2016 Oct;9(5):395-407. PMID: 26970976

Harrington M, Hareendran A, Skalicky A, Wilson H, Clark M, Mikl J. Assessing the impact on caregivers for patients with rare lysosomal storage diseases: development of the Caregiver Impact Questionnaire. Journal of Patient Reported Outcomes. 2019; 3 (44): 1-14.

Wilson H, Mannix S, Oko-osi H, Revicki DA. The impact of medication on health-related quality of life in patients with generalized anxiety disorder. CNS Drugs. 2015 Jan;29(1):29-40. Review. PMID: 25516469

Revicki, D.A., Althof, S. DeRogatis, L., Wilson, H., Jordan, R., Lucas, J. Reliability and Validity of the Elements of Desire Questionnaire in the Bremelanotide RECONNECT Study. International Society for the Study of Women’s Sexual Health Annual Meeting, Atlanta, GA, February 2017.

Revicki, D.A., Althof, S. DeRogatis, L., Wilson, H., Jordan, R., Lucas, J. Measuring elements of desire in the Bremelanotide RECONNECT Study. American Society of Clinical Psychopharmacology Meeting, Miami, FL June 2017.

Koochaki PE, Revicki DA, Wilson H, Pokrzywinski R, Jordan R, Lucas J. Development of a patient-centric exit study to contextualize and assess meaningfulness of a potential treatment for hypoactive sexual desire disorder (HSDD). Nurse Practitioners in Women’s Health. 11-14 Oct 2017. Seattle, WA, USA.

Koochaki P, Revicki DA, Wilson H, Pokrzywinski R, Jordan R, Lucas J. Bremelanotide provides meaningful treatment benefits for premenopausal women with hypoactive sexual desire disorder. The International Society for Sexual Medicine and The European Society for Sexual Medicine, World Meeting on Sexual Medicine. 28Feb- 3Mar 2018. Lisbon, Portugal.

Koochaki P, Revicki D, Wilson H, Pokrzywinski R, Jordan R, Lucas J. Exit survey of women with HSDD treated with Bremelanotide demonstrates meaningful treatment benefits. The American College of Obstetricians and Gynecologists. 27-30 April 2018. Austin, TX, USA.

Koochaki PE, Revicki D, Wilson H, Pokrzywinski R, Jordan R, Lucas J. Exit survey study data of women with HSDD treated with Bremelanotide demonstrated meaningful treatment benefits. Academy of Women’s Health. 3-6 May 2018. Washington, DC, USA.

Clayton AH, Althof S, DeRogatis L, Kingsberg S, Wilson H, Jordan R, Lucas J, Revicki D. Elements of Desire Questionnaire Assessment of Bremelanotide Efficacy for Hypoactive Sexual Desire Disorder in the RECONNECT Studies. 32nd European College of NeuropsychopharmacologyCongress 2019 7–10 September 2019 Copenhagen, Denmark

Jones PW, Gelhorn H, Wilson H, Dangeti R, Karlsson N, Kulich K, Menjoge S, Merrill DD, Mullerova H, Rennard SI, Tal-Singer R, Tabberer M. (May 2014). Changes in SGRQ score over 3 years in COPD patients categorized into low and high breathlessness using the MMRC score. Poster presented at the ATS International Conference, San Diego, CA, USA.

Jones PW, Gelhorn H, Wilson H, Dangeti R, Karlsson N, Kulich K, Menjoge S, Merrill DD, Mullerova H, Rennard SI, Tal-Singer R, Tabberer M. (May 2014). Effect of bronchodilator and placebo therapy on SGRQ score in COPD patients over 3 years: Difference between low/medium and high socio-economic countries. Poster presented at the ATS International Conference, San Diego, CA, USA.

Jones PW, Gelhorn H, Wilson H, Dangeti R, Karlsson N, Kulich K, Menjoge S, Merrill DD, Mullerova H, Rennard SI, Tal-Singer R, Tabberer M (May 2014). Large placebo effects on SGRQ score in clinical trials in low-medium income countries may not reduce measured bronchodilator efficacy. Poster presented at the 2014 ATS International Conference, San Diego, CA, USA.

Jones PW, Gelhorn H, Karlsson N, Menjoge S, Müllerova H, Rennard SI, Tal-Singer R, Wilson H, Merrill D, Tabberer M. Baseline Severity as Predictor of Change in St George’s Respiratory Questionnaire Scores in Trials of Long-acting Bronchodilators with COPD Patients. Chronic Obstr Pulm Dis (Miami). 2017; 4(2): 132-140.

Jones PW, Gelhorn H, Wilson H, Karlsson N, Menjoge S, Müllerova H, Rennard SI, Tal-Singer R, Merrill D, Tabberer M. Responder Analyses for Treatment Effects in COPD Using the St George’s Respiratory Questionnaire. Chronic Obstr Pulm Dis (Miami). 2017; 4(2): 124-131.

Jones PW, Gelhorn H, Wilson H, Benson VS, Karlsson N, Menjoge S, Müllerova H, Rennard SI, Tal-Singer R, Merrill D, Tabberer M. Socioeconomic status as a determinant of health status treatment response in COPD trials. Chronic Obstructive Pulmonary Diseases, 2017; 4(2):150-158.

Müllerova H, Gelhorn H, Wilson H, Benson VS, Karlsson N, Menjoge S, Rennard SI, Tabberer M, Tal-Singer R, Merrill D, Jones PW. St. George’s Respiratory Questionnaire score predicts outcomes in patients with COPD: Analysis of individual patient data in the COPD Biomarkers Qualification Consortium. Chronic Obstructive Pulmonary Diseases, 2017; 4(2):141-149.

Jones PW, Gelhorn H, Karlsson N, Menjoge S, Müllerova H, Rennard SI, Tal-Singer R, Wilson H, Merrill D, Tabberer M. Baseline severity as a predictor of change in St. George’s Respiratory Questionnaire Scores in Trials of Long-Acting Bronchodilators with COPD Patients. Chronic Obstructive Pulmonary Diseases, 2017; 4(2):132-140.

Jones PW, Gelhorn H, Wilson H, Karlsson N, Menjoge S, Müllerova H, Rennard SI, Tal-Singer R, Merrill D, Tabberer M. Responder Analyses for Treatment Effects in COPD Using the St. George’s Respiratory Questionnaire Dataset. Chronic Obstructive Pulmonary Diseases, 2017; 4(2):124-131.

Tabberer M Benson VS, Gelhorn H, Wilson HD, Karlsson N, et al. The COPD Foundation Biomarkers Qualification Consortium Database: Baseline Characteristics of the St. George’s Respiratory Questionnaire Dataset. Chronic Obstructive Pulmonary Diseases, 2017; 4(2):112-123.

Revicki D, Wilson H, Pinto L, Viswanathan HN. (October 2014). Experience of pain in patients with moderate to severe plaque psoriasis. Poster presented at the 21st ISOQOL Annual Conference, Berlin, Germany.

Mease PJ, Genovese MC, Mutebi A, Wilson H, Revicki DA, Erondu N, Nirula A, Feng JY, Viswanathan HN. (November 2014). Reliability and construct validity of the Psoriasis Symptom Inventory (PSI) in subjects with Psoriatic Arthritis. Poster presented at the American College of Rheumatology Annual Scientific Meeting, Boston, MA, USA.

Viswanathan HN, Mutebi A, Milmont CE, Gordon K, Wilson H, Zhang H, Klekotka P, Revicki D, Augustin M, Kricorian G, Nirula A, Strober B (May 2015). Measurement properties of the patient-reported Psoriasis Symptom Inventory (PSI) daily diary in patients with moderate to severe plaque psoriasis. Poster presented at the 20th ISPOR Annual International Meeting, Philadelphia, PA, USA.

Swigris J, Wilson H, Esser D, Conoscenti CS, Stansen W, Leidy NK, Brown K. (October 2015). Psychometric properties of the St. George’s Respiratory Questionnaire in the INPULSIS® trials of idiopathic pulmonary fibrosis (IPF). Poster presented at the American College of Chest Physicians (CHEST) Conference, Montreal, Canada.

Swigris JJ, Esser D, Wilson H, Conoscenti C, Schmidt H, Stansen W, Leidy NK, Brown KK (2017). Psychometric properties of the St. George’s Respiratory Questionnaire in patients with idiopathic pulmonary fibrosis. European Respiratory Journal. Jan 18:49(1).

Revicki DA, Jin Y, Wilson HD, Chau D, Viswanathan HN. Reliability and validity of the psoriasis symptom inventory in patients with moderate-to-severe psoriasis. J Dermatolog Treat. 2014 Feb;25(1):8-14. Epub 2013 Jun 11. PMID: 23339373

Wilson HD, Mutebi A, Revicki DA, Mease PJ, Genovese MC, Erondu N, Nirula A, Yuan FJ, Viswanathan HN. Reliability and Validity of the Psoriasis Symptom Inventory in Patients with Psoriatic Arthritis. Arthritis Care Res (Hoboken). 2015 Dec;67(12):1750-6.

Viswanathan HN, Mutebi A, Milmont CE, Gordon K, Wilson H, Zhang H, Klekotka PA, Revicki DA, Augustin M, Kricorian G, Nirula A, Strober B. Measurement Properties of the Psoriasis Symptom Inventory Electronic Daily Diary in Patients with Moderate to Severe Plaque Psoriasis. Value Health, 2017; 20 (8): 1174-1179.

Kreuter M, Hoffmann-Vold AM, Matucci-Cerinic M, Saketkoo LA, Highland KB, Wilson H, das Alves M, Schoof, N, Maher TM. Health-Related Quality of Life In Patients With Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD): Impact of Lung Function On Patient-Reported Outcomes In a Randomized Phase III Trial’. American College of Rheumatology 2019. 8-13 November 2019 Atlanta GA, USA.

LaGraize, SC, Borzan, J, Waldo, H, Peng, YB, and Fuchs, PN. Morphine and GABA administration in the rostral anterior cingulate cortex alters supraspinal processing of nociception. American Pain Society, 2004, Vancouver, Canada.

Peng, YB, Senapati, AK, LaGraize, SC, Waldo, H, and Fuchs, PN. Electrical stimulation of the anterior cingulate cortex reduces responses of rat dorsal horn neurons to mechanical stimuli. American Pain Society, 2004, Vancouver, Canada.

Senapati, AK, LaGraize, SC, Waldo, HD, Fuchs, PN, and Peng, YB. Spinal dorsal horn neuron response to mechanical stimuli is decreased by stimulation of the primary motor and somatosensory cortices. American Pain Society, 2004, Vancouver, Canada.

LaGraize, SC, Wilson, HD, and Fuchs, PN. GABAA microinjected into the rostral anterior cingulate cortex effects supraspinal processing of nociception. Society for Neuroscience, 2004, San Diego, CA.

Senapati, AK, Lagraize, SC, Huntington, PJ, Wilson, HD, Fuchs, PN, Peng, YB. Electrical stimulation of the anterior cingulate cortex reduces responses of rat dorsal horn neurons to mechanical stimuli. J Neurophysiol. 2005; 94: 845-51. PMID: 15716373

Senapati, AK, Huntington, PJ, LaGraize, SC, Wilson, HD, Fuchs, PN, Peng, YB. Electrical stimulation of the primary somatosensory cortex inhibits spinal dorsal horn neuron activity. Brain Res. 2005; 1057:134-40. PMID: 16122710

Allen, C, Fuchs, PN, Shriver, A, and Wilson, HD. Deciphering animal pain. In: Murat Aydede, ed. Pain: New Essays on its Nature and the Methodology of its Study. MIT Press, 2005, 351-366.

Wilson, HD, Wilson, JR, Fuchs, PN. Hyperbaric oxygen treatment decreases inflammation and mechanical hypersensitivity in an animal model of inflammatory pain. Brain Res. 2006; 1098:126-8. PMID: 16750177

Weaver, RR, Hagains, CE, Davis, JA, Wilson, HD, Peng, YB, and Fuchs, PN. Increased sensitivity to mechanical stimulation in an animal model of multiple sclerosis. Southwestern Psychological Association, 2006, Austin, TX.

Wilson, HD, Toepfer, VE, Senapati, AK, Wilson, JR, and Fuchs, PN. Hyperbaric oxygen treatment decreases edema and mechanical hypersensitivity in animal models of acute inflammation and arthritis. Society for Neuroscience, 2006, Atlanta, GA.

Boyette-Davis, JA, Thompson, CD, Wilson, HD, and Fuchs, PN. The impact of pain on attentional processing. Society for Neuroscience, 2006, Atlanta. Wilson, HD. Hyperbaric oxygen treatment for inflammatory pain. Presentation at the Annual Scientific Conference for University of Texas at Arlington, 2006, Arlington, TX.

Wilson, HD, Toepfer, VE, Senapati, AK, Wilson, JR, and Fuchs, PN. Hyperbaric oxygen treatment is comparable to acetylsalicylic acid treatment in an animal model of arthritis. J Pain. 2007; 12: 924-930.

Wilson, HD, Boyette-Davis, J, Fuchs, PN. The relationship between basal level of anxiety and the affective response to inflammation. Physiol Behav. 2007; 90:506-11. PMID: 17174362

Wilson, HD, Toepfer, VE, Senapati, AK, Wilson, JR, Fuchs, PN. Hyperbaric oxygen treatment is comparable to acetylsalicylic acid treatment in an animal model of arthritis. J Pain. 2007; 8:924-30. PMID: 17690013

Wilson H, Robinson JP, Swanson KS, Turk DC. Emotional Factors in the Onset and Aggravation of Fibromyalgia Symptoms: Results of an Internet Survey. Poster presented at the 27th annual scientific meeting of the American Pain Society, 2008, Tampa, Florida.

Turk DC, Robinson JP, Swanson KS, Wilson H. Effectiveness of Psychological Therapies in the Rehabilitation of Individuals with Fibromyalgia: Responder Analysis. Poster presented at the 27th annual scientific meeting of the American Pain Society, 2008, Tampa, Florida, 2008.

Swanson KS, Wilson H, Robinson JP, Turk DC. The Effectiveness of Three Psychological Therapies in the Rehabilitation of Fibromyalgia Patients: A Randomized Controlled Trial. Poster presented at the 27th annual scientific meeting of the American Pain Society, 2008, Tampa, Florida.

Robinson JP, Wilson H, Swanson KS, Turk DC. Symptom Reporting in People with Fibromyalgia– High and Low Endorsers. Poster presented at the 27th annual scientific meeting of the American Pain Society, 2008, Tampa, Florida.

Wilson, HD, Uhelski, ML, Fuchs, PN. Examining the role of the medial thalamus in modulating the affective dimension of pain. Brain Res. 2008; 1229: 90-9. PMID: 18625207

Turk DC, Wilson HD. Psychosocial issues in fibromyalgia. In: McCarberg B, Clauw D, eds. Fibromyalgia. New York: InformaHealth; 2009:81-103.

Turk DC, Swanson KS, Wilson HD. Psychological approaches in pain management. In: Sluka K, ed. Textbook of Pain for Physical Therapists. Seattle, WA: IASP Press; 2009:257-275.

Wilson, HD, Robinson, JP, Turk, DC. Toward the identification of symptom patterns in people with fibromyalgia. Arthritis Care & Research. 2009; 61: 527-34. PMID: 19333980

Wilson HD, Starz TW, Robinson JP, Turk DC. Heterogeneity within the fibromyalgia population: theoretical implications of variable tender point severity ratings. J Rheumatol. 2009 Dec;36(12):2795-801. doi: 10.3899/jrheum.090432. Epub 2009 Nov 16. PMID: 19918043.

Robinson JP, Wilson, HD, Turk DC. Physical and psychological characteristics of opioid users and non-opioid users participating in a fibromyalgia rehabilitation program. Poster to be presented at the 28th annual scientific meeting of the American Pain Society, 2009, San Diego, California.

Turk DC, Robinson JP, Wilson, HD. Effects of opioid use on treatment entry, completion, and outcomes for a rehabilitative program for fibromyalgia patients. Poster to be presented at the 28th annual scientific meeting of the American Pain Society, 2009, San Diego, California.

Wilson H, Robinson JP, Turk DC. The relationship between demographic, physical capacity, and psychological variables and tender points in fibromyalgia patients. Poster presented at the 28th annual scientific meeting of the American Pain Society, 2009, San Diego, California.

Turk DC, Wilson HD. Pain, suffering, pain-related suffering – are these constructs inextricably linked? [Editorial] Clin J Pain. 2009;25:353-355.

Turk DC, Wilson HD. Managing fibromyalgia: an update on diagnosis and treatment. J Musculoskeletal Med 2009;supplement: S1-S7.

Turk DC, Wilson HD. Psychological factors in chronic pain. In: Rossi P, ed. Corsini’s Encyclopedia of Psychology. Hoboken, NJ: John Wiley & Sons, 2010:314-17.

Turk DC, Swanson KS, Wilson HD. Psychological aspects of pain. In: Ballantyne J, Rathmell J, Fishman S, eds. Bonica’s Management of Pain, 4th ed. Philadelphia: Lippincott, Williams & Wilkins; 2010:74-85.

Kemp CA, Theodore BR, Wilson HD, Robinson JP, Turk DC. Assessment of the long-term stability of symptoms and outcome measures for chronic pain clinical trials. Poster presented at the annual Society for Behavioral Medicine meeting, 2010, Seattle, WA.

Starz TW, Wilson HD, Robinson JP, Theodore BR, Turk DC. The effect of baseline tender point severity on treatment outcome in pregabalin clinical trials. Poster presented at the 28th annual scientific meeting of the American Pain Society, 2010, Baltimore, Maryland.

Cahana A, Theodore BR, Rapp S, Wilson HD, Robinson JR, Turk DC. Treatment History, Patient Satisfaction, and Expectations: Preliminary Observations from a Comprehensive Patient Registry. Poster presented at the 28th annual scientific meeting of the American Pain Society, 2010, Baltimore, Maryland.

Wilson HD, Kemp CA, Theodore BR, Kim M, Turk DC. A Nationally Representative Survey of Clinicians Attitudes and Behaviors Regarding Long-term Use of Opioid. Poster presented at the 28th annual scientific meeting of the American Pain Society, 2010, Baltimore, Maryland.

Landau R, Wilson HD, Flint L, Kraft J, Turk DC. Stability of diffuse noxious inhibitory controls in women: within menstrual cycle fluctuations and across menstrual cycle consistency. Poster presented at the 28th annual scientific meeting of the American Pain Society, 2010, Baltimore, Maryland.

Turk DC, Theodore BR, Wilson HD. The Clinical Meaningfulness of Treatment Outcomes – Achieving Pain <4. Poster presented at the 28th annual scientific meeting of the American Pain Society, 2010, Baltimore, Maryland.

Turk DC, Robinson JR, Fillingim R, Wilson HD. Controversies regarding the etiology and pathophysiology of Fibromyalgia: the role of genetics, biological factors, psychosocial stress, and trauma. Symposium presented at the 28th annual scientific meeting of the American Pain Society, 2010, Baltimore, Maryland.

Landau R, Wilson HD, Ruehlmann S, Kraft JC, Carvalho B. Testing reliability of repeated measures of diffuse noxious inhibitory control (DNIC) in women. Poster presented at the 2010 Annual meeting for American Society for Anesthesiologists, 2010, San Diego, California.

Turk DC, Swanson KS, Wilson HD. The biopsychosocial model of pain and pain management. In: Kern RD, Ebert M., eds. Behavioral and Pharmacological Pain Management. New York: Cambridge University Press; 2011: 16-43.

Turk DC, Wilson HD, Swanson KS. Models of chronic pain. In: Baum A, Revenson T, Singer J, eds. Handbook of Health Psychology. 2nd ed. Hillsdale, NJ: Erlbaum; 2011.

Turk DC, Wilson HD. Fear of pain as a prognostic factor in chronic pain: conceptual models, assessment, and treatment implications. Curr Pain Headache Rep. 2010 Apr;14(2):88-95. doi: 10.1007/s11916-010-0094-x. PMID: 20425197; PMCID: PMC2872063.

Wilson HD, Mayer TG, Gatchel RJ. The lack of association between changes in functional outcomes and work retention in a chronic disabling occupational spinal disorder population: implications for the minimum clinical important difference. Spine (Phila Pa 1976). 2011 Mar 15;36(6):474-80. doi: 10.1097/BRS.0b013e3181d41632. PMID: 20881518; PMCID: PMC2951680.

Robinson JP, Theodore BR, Wilson HD, Waldo PG, Turk DC. Determination of fibromyalgia syndrome after whiplash injuries: methodologic issues. Pain. 2011 Jun;152(6):1311-1316. doi: 10.1016/j.pain.2011.02.002. Epub 2011 Mar 17. PMID: 21419574; PMCID: PMC3098908.

Bruchas RR, Kent CD, Wilson HD, Domino KB. Anesthesia awareness: narrative review of psychological sequelae, treatment, and incidence. J Clin Psychol Med Settings. 2011 Sep;18(3):257-67. Review. PMID: 21512752

Turk DC, Wilson HD, Cahana A. Treatment of Chronic Non-cancer Pain. Lancet, 2011 Jun 25; 377(9784):2226-35.PMID: 21704872

Cahana A, Theodore BR, Wilson HD, Stoner SA, Robinson J, Turk DC. Characteristics of patients prescribed opioid versus non-opioid medication: preliminary observations from a comprehensive patient registry. Poster presented at the 2011 Annual meeting for International Association for the Study of Pain.

Skinner, M., Wilson, H. D., & Turk, D. C. (2012). Cognitive-behavioral perspective and cognitive-behavioral therapy for people with chronic pain: Distinctions, outcomes, and innovations. Journal of Cognitive Psychotherapy, 26(2), 93–113.

Cahana A, Dansie EJ, Theodore BR, Wilson HD, Turk DC. Redesigning delivery of opioids to optimize pain management, improve outcomes, and contain costs. Pain Med. 2013 Jan;14(1):36-42. doi: 10.1111/pme.12013. Epub 2012 Dec 28. PMID: 23279325.

Robinson JP, Theodore BR, Dansie EJ, Wilson HD, Turk DC. The role of fear of movement in subacute whiplash-associated disorders grades I and II. Pain. 2013 Mar;154(3):393-401. doi: 10.1016/j.pain.2012.11.011. Epub 2012 Dec 1. PMID: 23318127; PMCID: PMC3582794.

Wilson HD, Dansie EJ, Kim MS, Moskovitz BL, Chow W, Turk DC. Clinicians’ attitudes and beliefs about opioids survey (CAOS): instrument development and results of a national physician survey. J Pain. 2013 Jun;14(6):613-27. doi: 10.1016/j.jpain.2013.01.769. Epub 2013 Mar 26. PMID: 23541067.

Turk DC, Wilson HD. Chronic Pain. In: Weiner I, Nezu A, Nezu CM, Gellered PA, eds. Comprehensive Handbook of Psychology, volume 9: Health Psychology. 2nd ed. New York: Wiley; 2012.

Dworkin RH, Allen R, Kopko S, Lu Y, Turk DC, Burke LB, Desjardins P, Etropolski M, Hewitt DJ, Jayawardena S, Lin AH, Malamut R, Michel D, Ottinger J, Peloso P, Pucino F, Rappaport BA, Skljarevski V, St Peter D, Timinski S, West CR, Wilson HD. A standard database format for clinical trials of pain treatments: an ACTTION-CDISC initiative. Pain. 2013 Jan;154(1):11-4. Epub 2012 Oct 26. PMID: 23218970

Wilson H, Carvalho B, Granot M, Landau R. Temporal stability of conditioned pain modulation in healthy women over four menstrual cycles at the follicular and luteal phases. Pain. 2013 Dec;154(12):2633-8. Epub 2013 Jun 27. PMID: 23811040

Turk DC, Dansie EJ, Wilson HD, Moskovitz B, Kim M. Physicians’ beliefs and likelihood of prescribing opioid tamper-resistant formulations for chronic noncancer pain patients. Pain Med. 2014 Apr;15(4):625-36. doi: 10.1111/pme.12352. Epub 2014 Jan 21. PMID: 24612185.

Wilson H, Datto C, LoCasale R, Coyne K, Tack J (June 2014). The patient impact of opioid-induced constipation (OIC) on pain management and GI symptoms. Poster presented at the 2014 International Conference on Opioids, Boston, MA, USA.

Datto C, LoCasale R, Wilson H, Coyne K, Tack J (July 2014). The patient impact of opioid-induced constipation (OIC) on pain management and GI symptoms [Encore Presentation]. Poster presented at the 2014 EU WONCA meeting, Lisbon, Portugal.

Datto C, LoCasale R, Wilson H, Coyne K. (September 2014). The impact of opioid-induced constipation (OIC) on pain management. Poster presented at Painweek 2014, Las Vegas, NV, USA.

Robinson JP, Dansie EJ, Wilson HD, Rapp S, Turk DC. Attitudes and Beliefs of Working and Work-Disabled People with Chronic Pain Prescribed Long-Term Opioids. Pain Med. 2015 Jul;16(7):1311-24. doi: 10.1111/pme.12770. Epub 2015 Apr 30. PMID: 25929427.

Datto C, LoCasale R, Wilson H, Coyne K (September 2015). Does the impact of opioid-induced constipation differ by type of chronic pain? Poster presented at Painweek 2015, Las Vegas, NV, USA.

Datto C, LoCasale R, Wilson H, Coyne K. (September 2015). Discordance between patient and healthcare provider reports of the burden of opioid-induced constipation. Poster presented at the American Society for Pain Management Nursing 25th National Conference, Atlanta, GA, USA.

Datto C, LoCasale R, Wilson H, Coyne K (June 2015). Discordance between patient and healthcare provider reports of the burden of opioid-induced constipation. Poster presented at the ICOO International Conference on Opioids, Boston, MA, USA.

Datto C, LoCasale R, Wilson H, Coyne K. (June 2015). The impact of opioid-induced chronic pain on pain management. Poster presented at the AANP National Conference, New Orleans, LA, USA.

Smith SM, Hunsinger M, McKeown A, Parkhurst M, Allen R, Kopko S, Lu Y, Wilson HD, Burke LB, Desjardins P, McDermott MP, Rappaport BA, Turk DC, Dworkin RH. Quality of pain intensity assessment reporting: ACTTION systematic review and recommendations. J Pain. 2015 Apr;16(4):299-305. doi: 10.1016/j.jpain.2015.01.004. Epub 2015 Jan 28. PMID: 25637296.

Carvalho B, Granot M, Sultan P, Wilson H, Landau R. A Longitudinal Study to Evaluate Pregnancy-Induced Endogenous Analgesia and Pain Modulation. Reg Anesth Pain Med. 2016 Mar-Apr;41(2):175-80. doi: 10.1097/AAP.0000000000000359. PMID: 26866295.

LoCasale RJ, Datto C, Wilson H, Yeomans K, Coyne KS. The Burden of Opioid-Induced Constipation: Discordance Between Patient and Health Care Provider Reports. J Manag Care Spec Pharm. 2016 Mar;22(3):236-45. doi: 10.18553/jmcp.2016.22.3.236. PMID: 27003553; PMCID: PMC10397844.

Smith SM, Dworkin RH, Turk DC, McDermott MP, Eccleston C, Farrar JT, Rowbotham MC, Bhagwagar Z, Burke LB, Cowan P, Ellenberg SS, Evans SR, Freeman RL, Garrison LP, Iyengar S, Jadad A, Jensen MP, Junor R, Kamp C, Katz NP, Kesslak JP, Kopecky EA, Lissin D, Markman JD, Mease PJ, O’Connor AB, Patel KV, Raja SN, Sampaio C, Schoenfeld D, Singh J, Steigerwald I, Strand V, Tive LA, Tobias J, Wasan AD, Wilson HD. Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations. Pain. 2020 Nov;161(11):2446-2461. doi: 10.1097/j.pain.0000000000001952. PMID: 32520773; PMCID: PMC7572524.